Freeze-drying process for preparation of bortezomib for injection
A technology for bortezomib and injection, which is applied in the field of freeze-drying technology for preparing bortezomib for injection, which can solve the problems of poor resolubility and other problems, and achieve the effects of qualified clarity, good resolubility and high product safety
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2017-01-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, and in particular relates to a freeze-drying process for preparing bortezomib for injection. Background technique
[0002] Bortezomib (PS-341) is a dipeptidyl boronic acid compound with high efficiency and specific proteasome inhibition. Approved by the FDA for listing, the trade name is The dosage form is freeze-dried powder injection (injection), which is used for the treatment of multiple myeloma and mantle cell lymphoma. Xi'an Janssen Pharmaceutical Co., Ltd. obtained the import registration approval of bortezomib for injection in China in March 2005.
[0003] Bortezomib is poorly soluble in water. The existing preparation methods of bortezomib for injection mostly use tert-butanol to solubilize, but after lyophilization, the preparation needs to be reconstituted with 0.9% sodium chloride injection, which has difficulties in reconstitution and poor clarity. Unqualified question. In addi...
Examples
Embodiment 1
[0036] Embodiment 1 (sample 1)
[0037] The subpackaged bortezomib intermediate medicinal solution is freeze-dried by the following freeze-drying process:
[0038] (1) Pre-freezing stage: evenly put the bottles containing the liquid medicine into the freeze dryer;
[0039] (1.1) Lower the temperature of the plate layer from room temperature to -50°C at a rate of 1.5°C / min, and keep it warm for 2 hours;
[0040] (1.2) Raise the temperature of the plate layer to -12°C at a rate of 1°C / min, and keep it warm for 3 hours;
[0041] (1.3) Cool down the plate layer to -50°C at a rate of 1°C / min and keep it warm for 2 hours;
[0042] (1.4) Raise the temperature of the plate layer to -12°C at a rate of 1°C / min, and keep it warm for 3 hours;
[0043] (1.5) Cool down the plate layer to -50°C at a rate of 1°C / min and keep it warm for 3 hours;
[0044] (2) Sublimation drying:
[0045] (2.1) After pre-freezing, start vacuuming, control the vacuum degree to 20Pa, and raise the temperatur...
Embodiment 2
[0050] Embodiment 2 (sample 2)
[0051] The subpackaged bortezomib intermediate medicinal solution is freeze-dried by the following freeze-drying process:
[0052] (1) Pre-freezing stage: evenly put the bottles containing the liquid medicine into the freeze dryer;
[0053] (1.1) Lower the temperature of the plate layer from room temperature to -50°C at a rate of 1.5°C / min, and keep it warm for 2 hours;
[0054] (1.2) Heat the plate layer to -10°C at a rate of 1°C / min and keep it warm for 2 hours;
[0055] (1.3) Cool down the plate layer to -50°C at a rate of 1°C / min and keep it warm for 2 hours;
[0056] (1.4) Raise the temperature of the plate layer to -10°C at a rate of 1°C / min and keep it warm for 2 hours;
[0057] (1.5) Cool down the plate layer to -50°C at a rate of 1°C / min and keep it warm for 3 hours;
[0058] (2) Sublimation drying:
[0059] (2.1) After pre-freezing, start vacuuming, control the vacuum degree to 20Pa, and raise the temperature of the plate layer t...